When analyzing LABU's prospects, it is ok to use its non-leveraged counterpart, XBI - the SPDR S&P Biotech ETF. In that article, I published a chart dated 21 June when I decided to write the article.

LABU - Direxion Daily Biotech Bull 3X Shares ETF. Fund Details. Fund Type Miscellaneous. Issuer Direxion Funds. Inception 05/28/2015. Expense Ratio 1.01%. AUM $1.23B # of Holdings 145 *Holdings as ...

LABU fell to the $5.97 flat lower trendline but collapsed through March 2023 as shares reached a new swing low of $4.57. Pullback support levels are at $4.57, $4.06, $3.40, and $2.52.